- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Long COVID patient advocates and public health officials are deeply concerned and seeking clarity on whether the Trump administration actually has a plan to address the disease, which at least 20 million Americans have been diagnosed with, after HHS abruptly rescinded nearly $11.4 billion in COVID-19-related funding for state and local health departments and shut down the federal Office of Long COVID Research and Practice (OLC) last week.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us